The effect of fat intake and antihypertensive drug therapy on serum lipid profile: A cross-sectional survey of serum lipids in male and female hypertensives

Molecular and Cellular Biochemistry

Volumn 343, Issue 1-2, 2010, Pages 37-47

  Sharma, Rakesh ^a   Raghuram, T C ^a   Rao, U Brahmoji ^b   Moffatt, Robert J ^c   Krishnaswamy, Kamla ^a  

^a NATIONAL INSTITUTE OF NUTRITION   (India)

^b OSMANIA GENERAL HOSPITAL   (India)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Anthropometry; Antihypertensive therapy; Betablocker; Diuretics; Fat; Hypertension; Lipid; Thiazide

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BENZTHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FUROSEMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLDOPA; METOPROLOL; POLYUNSATURATED FATTY ACID; PROPRANOLOL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL; TRIAMTERENE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FAT INTAKE; HYPERTENSION; LIPID BLOOD LEVEL; LIPID METABOLISM; LOW FAT DIET; OBESITY; SEX DIFFERENCE; SODIUM RESTRICTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTIHYPERTENSIVE AGENTS; CROSS-SECTIONAL STUDIES; DIETARY FATS; FEMALE; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED;

EID: 77957591518     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0496-4     Document Type: Article

References (41)

1. BL Kasiske JZ Ma RS Kalil TA Louis 1995 Effects of antihypertensive therapy on serum lipids Ann Intern Med 122 2 133 141 1:STN:280: DyaK2M%2FosFWmug%3D%3D 7992988
2. U Hauf-Zachariou L Widmann B Zülsdorf M Hennig PD Lang 1993 A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia Eur J Clin Pharmacol 45 2 95 100 1:STN:280: DyaK2c%2FjvFeltA%3D%3D 10.1007/BF00315487 8223847
3. JD Neaton RH Grimm Jr RJ Prineas J Stamler GA Grandits PJ Elmer JA Cutler JM Flack JA Schoenberger R McDonald, et al. 1993 Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group JAMA 270 6 713 724 1:STN:280:DyaK3szivFOmtg%3D%3D 10.1001/jama.270.6.713 8336373 (Pubitemid 23226630)
4. J Ostman K Asplund T Bystedt B Dahlöf S Jern T Kjellström H Lithell 1998 Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group J Intern Med 244 2 95 107 1:CAS:528:DyaK1cXlslWltLo%3D 10.1046/j.1365-2796.1998.00319.x 10095796 (Pubitemid 28364795)
5. OP Foss S Graff-Iversen H Istad E Søyland L Tjeldflaat B Graving 1999 Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention Scand J Prim Health Care 17 2 122 127 1:STN:280: DyaK1MzmvVemsA%3D%3D 10.1080/028134399750002764 10439497 (Pubitemid 29339650)
6. NF Gordon CB Scott JJ Duncan 1997 Effects of atenolol versus enalapril on cardiovascular fitness and serum lipids in physically active hypertensive men Am J Cardiol 79 8 1065 1069 1:CAS:528:DyaK2sXjtVKntLw%3D 10.1016/S0002-9149(97) 00048-9 9114765 (Pubitemid 27217060)
7. PJ Savage SL Pressel JD Curb EB Schron WB Applegate HR Black J Cohen, et al. 1998 Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group Arch Intern Med 158 7 741 751 1:CAS:528:DyaK1cXislCjsbo%3D 10.1001/archinte.158.7.741 9554680 (Pubitemid 28204659)
8. NC López JL Corral LA Rincón MR Arreaza J Giralt GA Galué YE Barrios I Arocha 1991 Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass J Cardiovasc Pharmacol 18 Suppl 1 S101 S105 1723446
9. RH Grimm Jr JM Flack GA Grandits PJ Elmer JD Neaton JA Cutler C Lewis R McDonald J Schoenberger J Stamler 1996 Long-term effects on plasma lipids of diet and drugs to treat hypertension Treatment of Mild Hypertension Study (TOMHS) Research Group JAMA 275 20 1549 1556 1:CAS:528:DyaK28XjsFWgsrY%3D 10.1001/jama.275.20.1549 8622245 (Pubitemid 26154240)
10. M Diestelhorst LI Larsson European-Canadian Latanoprost Fixed Combination Study Group 2006 A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components Ophthalmology 113 1 70 76 10.1016/j.ophtha.2005.06.027 16263174 (Pubitemid 43021730)
11. MR Lakshman DJ Reda BJ Materson WC Cushman ED Freis 1999 Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents Arch Intern Med 159 6 551 558 1:CAS:528:DyaK1MXitFChsrw%3D 10.1001/archinte.159.6.551 10090111 (Pubitemid 29133879)
12. R Fogari A Zoppi L Corradi P Preti A Mugellini P Lusardi 1999 Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia J Cardiovasc Pharmacol 33 4 534 539 1:CAS:528:DyaK1MXisFWns7Y%3D 10.1097/00005344-199904000-00004 10218722 (Pubitemid 29164815)
13. O Batic-Mujanovic A Beganlic N Salihefendic N Pranjic Z Kusljugic 2008 Influence of smoking on serum lipid and lipoprotein levels among family medicine patients Med Arh 62 5-6 264 267 19469266
14. Medical Research Council Working Party (1985) Medical Research Council trial on treatment of mild hypertension prospective results: Brit Med J 291:97
15. Williams GH, Braunwald E (2007) Hypertensive vascular disease. In: Braunwald E et al (eds) Harrison's "principles of internal medicine". McGraw Hill Book Company, New York, 1024 pp
16. D Sankar MR Rao G Sambandam KV Pugalendi 2006 Effect of sesame oil on diuretics or beta-blockers in the modulation of blood pressure, anthropometry, lipid profile and redox status Yale J Biol Med 79 1 19 26 1:CAS:528: DC%2BD1cXisFKgtrY%3D 17876372
17. A Salvetti L Ghiadoni 2006 Thiazide diuretics in the treatment of hypertension an update J Am Soc Nephrol 17 4 Suppl 2 S25 S29 1:CAS:528:DC%2BD28XjvFelsrk%3D 10.1681/ASN.2005121329 16565243
18. K Kozaki 2005 Management of elderly hypertensive individuals with hyperlipidemia Nippon Rinsho 63 6 1061 1066 15948391
19. JA Papadakis DP Mikhailidis GE Vrentzos A Kalikaki I Kazakou ES Ganotakis 2005 Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension Clin Appl Thromb Hemost 11 2 139 146 1:CAS:528:DC%2BD2MXktlWqsbY%3D 10.1177/107602960501100203 15821820 (Pubitemid 40547997)
20. LH Lindholm M Persson P Alaupovic B Carlberg A Svensson O Samuelsson 2003 Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) J Hypertens 21 8 1563 1574 1:CAS:528: DC%2BD3sXlvFartrY%3D 10.1097/00004872-200308000-00022 12872052 (Pubitemid 36994137)
21. DA McCarron ME Reusser 2001 Reducing cardiovascular disease risk with diet Obes Res 9 Suppl 4 335 340 10.1038/oby.2001.139
22. E Grossman FH Messerli 2002 Why beta-blockers are not cardioprotective in elderly patients with hypertension Curr Cardiol Rep 4 6 468 473 10.1007/s11886-002-0108-3 12379165
23. MR Weir M Moser 2000 Diuretics and beta-blockers: is there a risk for dyslipidemia? Am Heart J 139 1 Pt 1 174 183 1:CAS:528:DC%2BD3cXmtV2rsw%3D%3D 10.1016/S0002-8703(00)90325-9 10618579
24. R Ames 1998 Hyperlipidemia of diuretic therapy Arch Mal Coeur Vaiss 91 Suppl 23 27 9805566
25. HG Preuss JF Burris 1996 Adverse metabolic effects of antihypertensive drugs. Implications for treatment Drug Saf 14 6 355 364 1:CAS:528: DyaK28Xktlymt7k%3D 10.2165/00002018-199614060-00001 8828013
26. RR Wenzel 2005 Renal protection in hypertensive patients: selection of antihypertensive therapy Drugs 65 Suppl 2 29 39 1:CAS:528:DC%2BD2MXhtFKjur7I 10.2165/00003495-200565002-00005 16398060
27. JT Wright Jr G Bakris T Greene LY Agodoa LJ Appel J Charleston, et al. 2002 African American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 19 2421 2431 1:CAS:528:DC%2BD38XoslOktr8%3D 10.1001/jama.288.19.2421 12435255 (Pubitemid 35340538)
28. BH Rovin LA Hebert 2007 Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker Kidney Int 72 12 1423 1426 1:CAS:528:DC%2BD2sXhtlKltLrN 10.1038/sj.ki.5002656 18046421 (Pubitemid 350197960)
29. A Whelton 1999 Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications Am J Med 106 5B 13S 24S 1:CAS:528:DyaK1MXjvFOns74%3D 10.1016/S0002-9343(99)00113-8 10390124 (Pubitemid 29268660)
30. Hansson L (1987) Mild hypertension: guidelines for treatment. Report on WHO/ISH guidelines: workshop on treatment of mild hypertension: National Board of Health and Welfare. Drug Information committee, Sweden, 75 pp
31. Gopalan C, Ramashastri BV, Balasubramaniam (eds) Nutritive values of Indian foods. NVIF 2007. National Institute of Nutrition (ICMR) Publications, Hyderabad
32. Doumas BT, Biggs HG (1972) Determination of serum albumin. In: Cooper GR (ed) Standard methods of clinical chemistry, vol 7. Academic Press, New York, 175 pp
33. JEC Gustafsson 1976 Improved specificity of serum albumin determination and estimation of "acute phase reactants" by use of the bromcresol green reaction Clin Chem 22 616 622 1:CAS:528:DyaE28XktVajtrg%3D 4238
34. Senedicor GW, Cortron WG (1971) Statistical methods. Town State University Press, Iowa, 381 pp
35. HE Bays 2007 Safety considerations with omega-3 fatty acid therapy Am J Cardiol 99 6A 35C 43C 1:CAS:528:DC%2BD2sXjtFGltL8%3D 10.1016/j.amjcard.2006.11. 020 17368277 (Pubitemid 46412230)
36. MH Davidson EA Stein HE Bays KC Maki RT Doyle RA Shalwitz CM Ballantyne HN Ginsberg, et al. 2007 Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study Clin Ther 29 7 1354 1367 1:CAS:528:DC%2BD2sXhtVemurjN 10.1016/j.clinthera.2007.07.018 17825687 (Pubitemid 47348116)
37. RR Holman S Paul A Farmer L Tucker IM Stratton HA Neil, et al. 2009 Atorvastatin in factorial with omega-3 EE90 risk reduction in diabetes (AFORRD): a randomised controlled trial Diabetologia 52 1 50 59 1:CAS:528: DC%2BD1cXhsVCmsrfP 10.1007/s00125-008-1179-5 19002433
38. National Nutrition Monitoring Bureau Report (1984) National nutrition survey report. National Institute of Nutrition, Indian Council of Medical Research Publication, New Delhi, Hyderabad
39. Indian Council of Medical Research (1984) Recommended dietary intakes for Indians. Indian Council of Medical Research Publication, New Delhi, 18 pp
40. Sharma R, Moffatt RJ, Singh RB, Katz JK (2010) Carotid artery disease: lipid lowering vs side effects of statins. In: Watson RD, Pradee B (eds) Modern dietary fat intake: promotion of disease. Integrated Press, India, 434 pp
41. P Little G Girling A Hasler A Craven A Trafford 1990 The effect of a combination low sodium, low fat, high fibre diet on serum lipids in treated hypertensive patients Eur J Clin Nutr 44 4 293 300 1:STN:280: DyaK3czgsF2muw%3D%3D 1973094 (Pubitemid 20177217)